Mechanisms, prevalence and management of cardiac arrhythmias in cancer patients: a comprehensive review.

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Future cardiology Pub Date : 2023-11-01 Epub Date: 2023-11-06 DOI:10.2217/fca-2023-0086

Francesco Flore, Roberto Scacciavillani, Giulia Iannaccone, Maria Lucia Narducci, Gaetano Pinnacchio, Gianluigi Bencardino, Francesco Perna, Francesco Raffaele Spera, Gianluca Comerci, Massimiliano Camilli, Antonella Lombardo, Gaetano Antonio Lanza, Filippo Crea, Gemma Pelargonio

{"title":"Mechanisms, prevalence and management of cardiac arrhythmias in cancer patients: a comprehensive review.","authors":"Francesco Flore, Roberto Scacciavillani, Giulia Iannaccone, Maria Lucia Narducci, Gaetano Pinnacchio, Gianluigi Bencardino, Francesco Perna, Francesco Raffaele Spera, Gianluca Comerci, Massimiliano Camilli, Antonella Lombardo, Gaetano Antonio Lanza, Filippo Crea, Gemma Pelargonio","doi":"10.2217/fca-2023-0086","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, prognosis and survival of cancer patients has improved due to progression and refinement of cancer therapies; however, cardiovascular sequelae in this population augmented and now represent the second cause of death in oncological patients. Initially, the main issue was represented by heart failure and coronary artery disease, but a growing body of evidence has now shed light on the increased arrhythmic risk of this population, atrial fibrillation being the most frequently encountered. Awareness of arrhythmic complications of cancer and its treatments may help oncologists and cardiologists to develop targeted approaches for the management of arrhythmias in this population. In this review, we provide an updated overview of the mechanisms triggering cardiac arrhythmias in cancer patients, their prevalence and management.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"707-718"},"PeriodicalIF":1.6000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/fca-2023-0086","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Recently, prognosis and survival of cancer patients has improved due to progression and refinement of cancer therapies; however, cardiovascular sequelae in this population augmented and now represent the second cause of death in oncological patients. Initially, the main issue was represented by heart failure and coronary artery disease, but a growing body of evidence has now shed light on the increased arrhythmic risk of this population, atrial fibrillation being the most frequently encountered. Awareness of arrhythmic complications of cancer and its treatments may help oncologists and cardiologists to develop targeted approaches for the management of arrhythmias in this population. In this review, we provide an updated overview of the mechanisms triggering cardiac arrhythmias in cancer patients, their prevalence and management.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

癌症患者心律失常的机制、发病率和治疗：一项综合综述。

最近，由于癌症治疗的进展和完善，癌症患者的预后和生存率得到改善；然而，心血管后遗症在这一人群中增加，现在是肿瘤学患者死亡的第二大原因。最初，主要问题是心力衰竭和冠状动脉疾病，但现在越来越多的证据表明，这一人群的心律失常风险增加，心房颤动是最常见的。对癌症心律失常并发症及其治疗的认识可能有助于肿瘤学家和心脏病学家开发有针对性的方法来管理这一人群的心律失常。在这篇综述中，我们提供了癌症患者心律失常触发机制、发病率和管理的最新概述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

2.80

自引率

5.90%

发文量

期刊介绍： Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.